Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 122,480 | 0.1% | 158,680 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 91,557 | 0.1% | 162,835 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 86,165 | 0.1% | 164,123 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 105,343 | 0.1% | 166,096 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 119,592 | 0.1% | 167,889 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 182,017 | 0.2% | 173,145 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 182,592 | 0.2% | 173,727 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 166,558 | 0.2% | 173,049 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 150,540 | 0.2% | 171,401 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 140,512 | 0.2% | 170,740 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 126,865 | 0.2% | 176,560 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 147,670 | 0.2% | 179,719 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 130,986 | 0.2% | 181,549 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 123,907 | 0.2% | 179,870 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 106,474 | 0.2% | 180,120 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 123,800 | 0.2% | 177,257 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 117,328 | 0.1% | 185,787 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 107,263 | 0.1% | 177,241 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 98,452 | 0.1% | 176,266 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 88,053 | 0.1% | 186,103 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 89,381 | 0.1% | 185,012 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 101,086 | 0.2% | 180,581 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 109,245 | 0.2% | 175,170 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 71,153 | 0.2% | 145,718 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 54,905 | 0.1% | 146,227 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 43,746 | 0.1% | 145,683 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 39,905 | 0.1% | 144,983 | 12/31/2013 |